Literature DB >> 25680950

Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution.

Chieko Hamada1, Kazuho Honda, Kunio Kawanishi, Hirotaka Nakamoto, Yasuhiko Ito, Tsutomu Sakurada, Yudo Tanno, Toru Mizumasa, Masanobu Miyazaki, Misaki Moriishi, Masaaki Nakayama.   

Abstract

Peritoneal dialysis solution (PDS) plays a role in functional and morphological damage to the peritoneum. This study aimed to clarify the effect of neutral PDS in preventing morphological changes by assessing peritoneal damage and comparing morphological alterations between PD patients treated with neutral PDS and acidic PDS. Sixty-one patients participated from seven hospitals. All patients were treated with neutral PDS excluding icodextrin, during their entire PD treatment, and experienced no episode of peritonitis. The thickness of submesothelial compact (SMC) zone and the presence of vasculopathy in the anterior parietal abdominal peritoneum were assessed. The impact of icodextrin, hybrid therapy, and peritoneal rest and lavage in morphological alterations were determined. There was no significant difference in the average SMC thickness between neutral and acidic PDS. The vessel patency in patients using neutral PDS was significantly higher compared to that in acidic PDS at any time during PD. There were no significant suppressive effects from interventions or use of icodextrin with respect to peritoneal morphological injury. A monolayer of mesothelial cell was observed in approximately half the patients, especially in their receiving lavage patients. Neutral PDS, accompanied by other preventive approaches against peritoneal injury, might suppress the development of peritoneal morphological alterations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680950     DOI: 10.1007/s10047-015-0822-4

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  18 in total

1.  Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages.

Authors:  A Douvdevani; J Rapoport; A Konforty; R Yulzari; A Moran; C Chaimovitz
Journal:  J Am Soc Nephrol       Date:  1995-08       Impact factor: 10.121

2.  Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.

Authors:  T Liberek; N Topley; A Jörres; M M Petersen; G A Coles; G M Gahl; J D Williams
Journal:  Nephron       Date:  1993       Impact factor: 2.847

Review 3.  Biocompatibility studies on peritoneal cells.

Authors:  N Topley; G A Coles; J D Williams
Journal:  Perit Dial Int       Date:  1994       Impact factor: 1.756

4.  Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan.

Authors:  Nobuhiro Ayuzawa; Yoshitaka Ishibashi; Yutaka Takazawa; Haruki Kume; Toshiro Fujita
Journal:  Perit Dial Int       Date:  2011-07-31       Impact factor: 1.756

5.  Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels.

Authors:  S Jones; C J Holmes; R T Krediet; R Mackenzie; D Faict; A Tranaeus; J D Williams; G A Coles; N Topley
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

6.  Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients.

Authors:  Tetsutaro Shimaoka; Chieko Hamada; Kayo Kaneko; Hiroaki Io; Yoshimi Sekiguchi; Seiki Aruga; Jiro Inuma; Yuko Inami; Yoko Hotta; Satoshi Horikoshi; Toshio Kumasaka; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2010-04-22       Impact factor: 5.992

7.  Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.

Authors:  T Miyata; K Horie; Y Ueda; Y Fujita; Y Izuhara; H Hirano; K Uchida; A Saito; C van Ypersele de Strihou; K Kurokawa
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

Review 8.  Advanced glycation end-products and peritoneal sclerosis.

Authors:  Sakurako Nakamura; Toshimitsu Niwa
Journal:  Semin Nephrol       Date:  2004-09       Impact factor: 5.299

Review 9.  Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome?

Authors:  Alicja E Grzegorzewska
Journal:  Pol Arch Med Wewn       Date:  2009-04

10.  3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis.

Authors:  T Linden; G Forsbäck; R Deppisch; T Henle; A Wieslander
Journal:  Perit Dial Int       Date:  1998 May-Jun       Impact factor: 1.756

View more
  10 in total

Review 1.  Journal of Artificial Organs 2015: the year in review : Journal of Artificial Organs Editorial Committee.

Authors:  Y Sawa; K Matsuda; E Tatsumi; G Matsumiya; T Tsukiya; T Abe; K Fukunaga; A Kishida; K Kokubo; T Masuzawa; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2016-02-20       Impact factor: 1.731

2.  Outcomes of laparoscopic and open CAPD catheter placement: A single-center experience.

Authors:  Nicholas Prabhakar; Yazan N Aljamal; Humza Y Saleem; Mohamed S Baloul; Scott L Nyberg; David R Farley
Journal:  Surg Open Sci       Date:  2019-05-24

3.  Morphologic characteristics of macroscopic peritoneal finding in patients with peritoneal dialysis.

Authors:  Chieko Hamada; Hirotaka Nakamoto; Yusuke Suzuki
Journal:  J Artif Organs       Date:  2017-10-07       Impact factor: 1.731

4.  Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis.

Authors:  Naoya Sugiyama; Mitsuhiro Tawada; Ting Sun; Yasuhiro Suzuki; Hiroshi Kinashi; Makoto Yamaguchi; Takayuki Katsuno; Jan Aten; Carmen A Vlahu; Toin H van Kuppevelt; Yoshifumi Takei; Takuji Ishimoto; Shoichi Maruyama; Masashi Mizuno; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2021-05-17       Impact factor: 2.801

5.  Dissolved molecular hydrogen (H2) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity.

Authors:  Masaaki Nakayama; Wan-Jun Zhu; Kimio Watanabe; Ayano Gibo; Ali M Sherif; Shigeru Kabayama; Sadayoshi Ito
Journal:  BMC Nephrol       Date:  2017-10-31       Impact factor: 2.388

6.  Scavenging of reactive oxygen species by astaxanthin inhibits epithelial-mesenchymal transition in high glucose-stimulated mesothelial cells.

Authors:  Kazuaki Hara; Chieko Hamada; Keiichi Wakabayashi; Reo Kanda; Kayo Kaneko; Satoshi Horikoshi; Yasuhiko Tomino; Yusuke Suzuki
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

7.  A disposable, ultra-fine endoscope for non-invasive, close examination of the intraluminal surface of the peritoneal dialysis catheter and peritoneal cavity.

Authors:  Masaaki Nakayama; Chieko Hamada; Keitaro Yokoyama; Yudo Tanno; Nanae Matsuo; Junichiro Nakata; Yoshio Ishibashi; Atsushi Okuzawa; Kazuhiro Sakamoto; Tamaki Nara; Takatoshi Kakuta; Masaomi Nangaku; Takashi Yokoo; Yusuke Suzuki; Toshio Miyata
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

Review 8.  How peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease-what can we learn for future treatment?

Authors:  Maria Bartosova; Sotirios G Zarogiannis; Claus Peter Schmitt
Journal:  Mol Cell Pediatr       Date:  2022-05-05

9.  Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients.

Authors:  Mitsuhiro Tawada; Yasuhiko Ito; Chieko Hamada; Kazuho Honda; Masashi Mizuno; Yasuhiro Suzuki; Fumiko Sakata; Takeshi Terabayashi; Yoshihisa Matsukawa; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Yoshifumi Takei
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

Review 10.  Biocompatible Peritoneal Dialysis: The Target Is Still Way Off.

Authors:  Maria Bartosova; Claus Peter Schmitt
Journal:  Front Physiol       Date:  2019-01-07       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.